Arcus Biosciences RCUS
NYSE RCUS
$18.93 +0.65 (+3.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Arcus Biosciences (RCUS) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Arcus Biosciences' Net Equity Issued and Repurchased came in at $16 million for Q2 2026, up 433.3% from $3 million a year earlier and up 433.3% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported Net Equity Issued and Repurchased of $313 million, up 108.7% year-over-year; for FY2025, it was $439 million, up 85.2% from FY2024.

  • Net Equity Issued and Repurchased has increased in each of the last three years, though with a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $237 million in FY2024 (+618.2%), $33 million in FY2023 (+43.5%), $23 million in FY2022 (-90.1%) and $232 million in FY2021 (-61.5%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is -$213.91 million (Q4 2021) to $286 million (Q4 2025).
  • Year-over-year, Net Equity Issued and Repurchased increased in two of the last seven quarters, with growth averaging 75.8%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2023 (growth of 475.0%), and the weakest in Q1 2026 (a decline of 97.9%).
  • Business Quant data shows RCUS's Net Equity Issued and Repurchased at $3 million (Q1 2026), $286 million (Q4 2025) and $8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -966.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -5.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -283.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Arcus Biosciences 2.42 Bn -713.13 Mn - 7.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 7.00 Mn
Jun 30, 2026 16.00 Mn
Mar 31, 2026 3.00 Mn
Dec 31, 2025 286.00 Mn
Sep 30, 2025 8.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 142.00 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 2.00 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 229.00 Mn
Dec 31, 2023 3.00 Mn
Sep 30, 2023 6.00 Mn
Jun 30, 2023 23.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 6.00 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 4.00 Mn
Mar 31, 2022 10.00 Mn
Dec 31, 2021 -213.91 Mn
API Access

Arcus Biosciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RCUS&period=max&api_key=YOUR_API_KEY